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Cord Blood Cellular Proliferative Response as a Predictive Factor 
for Atopic Dermatitis at 12 Months 
Since the risk of developing allergic disease increases in individuals exposed to 
allergens previously, even during the neonatal period, the immunologic status of a 
fetus may be important in the subsequent development of allergy. We evaluated the 
fetal factors to predict atopic dermatitis (AD) at 12 months in 412 infants of a COhort 
for Childhood Origin of Asthma and Allergic Diseases (COCOA) in the general Korean 
population. Cord blood mononuclear cells (CBMCs) were stimulated with ovalbumin 
and phytohemagglutinin and cellular proliferative response and concentrations of 
interleukin-13 and interferon-γ, were measured. The risk of developing AD was 
greater in boys than girls (OR 1.97, 95% CI 1.26-3.09), infants delivered by cesarean 
section than vaginally (OR 1.93, 95% CI 1.14-3.26) and infants with than without 
parental history of AD (OR 2.34, 95% CI 1.29-4.24). The CBMC proliferative response 
to phytohemagglutinin stimulation was higher in infants with than without AD 
(P = 0.048), but no difference was observed in ovalbumin-stimulated cells 
(P = 0.771). Risk factors for the development of AD at 12 months include male 
gender, delivery by cesarean section and parental history of AD. Increased CBMC 
proliferative response to phytohemagglutinin stimulation may predict the 
development of AD at 12 months.
Key Words: Atopic Dermatitis; Cohort; Cord Blood; Cellular Proliferative Response; 
Cytokine; Risk Factor
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INTRODUCTION
Although allergic diseases are increasing recently both world-
wide and in Korea (1-4), the reason for these increases, their 
risk factors and the onset period for allergic disease have not 
been determined. The increased incidence of allergic diseases 
may result from changes in the environment rather than genet-
ic predisposition, with many studies attempting to identify the 
risk factors for development of allergic diseases (2, 3, 5). Early 
detection and prevention of allergic diseases in the neonatal 
period may be enhanced by identifying environmental factors 
that influence fetal and post-natal development of atopic dis-
ease (6, 7). 
 Allergic diseases originate in response to exposure during 
early life, with pregnancy and early childhood being critical pe-
riods for detecting early markers of allergic disease (8, 9). An im-
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munological bias toward atopy and asthma may be established 
in utero during the development of the fetal immune system (6, 
10) and may be detected by assays of cord blood. Because atop-
ic disease during early infancy may manifest as atopic dermati-
tis (AD), identifying factors associated with the development of 
AD, especially prenatally and in cord blood, may prevent the 
development of allergic diseases. Studies measuring IgE or me-
diators in cord blood and investigating their association with the 
development of asthma and other IgE-mediated allergic dis-
eases, however, have yielded conflicting results (11, 12), making 
it difficult to establish a causal relationship between these fac-
tors and the subsequent development of AD. 
 Cord blood T lymphocytes have been shown to proliferate 
when stimulated with ovalbumin, lactoglobulin or house dust 
mites, suggesting that priming has already occurred (13, 14) 
and that the fetal immune system may be primed for the devel-
opment of allergic disease before birth. It is unclear, however, 
whether cellular proliferative responses of cord blood will lead 
to the production of Th1/Th2 cytokines and allergic disorders. 
Defects in interferon (IFN)-γ secretion have been observed in 
the cord blood of individuals who later develop allergic disease 
and to be closely related to the cellular mechanisms underlying 
these diseases (15). Mediators of allergic disease development, 
however, have not been determined. We therefore assessed fac-
tors in newborns of the general Korean population that could 
affect the development of AD at 12 months. The factors that we 
investigated included family history of allergic disease, environ-
mental factors, and inflammatory status of cord blood.
MATERIALS AND METHODS
Study design 
We constructed a COhort for Childhood Origin of Asthma and 
Allergic Diseases (COCOA) in the general Korean population, by 
recruiting healthy pregnant women who delivered at four hos-
pitals (Asan Medical Center, Samsung Medical Center, Sever-
ance Hospital, and CHA Medical Center) beginning in Decem-
ber 2007. COCOA selection criteria were designed to enroll nor-
mal babies, so we excluded premature infants and those with 
congenital diseases. A modified questionnaire of the Interna-
tional Study of Asthma and Allergies in Childhood (ISAAC) was 
completed by each woman at 36 weeks of gestational age. This 
questionnaire includes questions about demographic factors in 
parents, parental medical histories including allergic diseases, 
environmental factors, and dietary pattern. The delivery record 
for each infant was written at birth. Cord blood samples were col-
lected from most subjects at the time of delivery. Each woman 
completed the same questionnaire when their infants reached 
6 and 12 months to assess demographic data, allergic disease 
history, environmental factors, and dietary pattern of the infants. 
Presence of AD was diagnosed by pediatric allergy specialists 
when the infants were followed-up at the hospital at 12 months. 
 Of the 1,294 pregnant women enrolled, 195 were excluded 
due to disagreement or failure to fulfill inclusion criteria. Cord 
blood was obtained from 790 infants. We identified 412 infants 
who were diagnosed with AD at 12 months by allergy specialists 
and for whom their parents completed questionnaires through 
12 months. Finally, we analyzed the association between AD at 
12 month and cord blood mediators in 287 infants.
Isolation of cord blood mononuclear cells and stimulation
Heparinized blood samples were obtained from full-term new-
born umbilical cords at birth. White blood cells (WBC) and eo-
sinophils were counted and total IgE levels were measured with 
CAP system (Pharmacia, Uppsala, Sweden). Cord blood mono-
nuclear cells (CBMCs) were separated on a Histopaque (Sigma 
Chemical Co., St Louis, USA) gradient within 24 hr of sample 
collection, and the collected cells were washed with phosphate-
buffered saline. CBMCs were cultured in Iscove’s modified Dul-
becco’s medium supplemented with 1% antibiotic-mycotic and 
10% fetal bovine serum (all from GIBCO BRL, Eggenstein, Ger-
many). CBMCs were re-suspended to 1 × 105 cells/200 µL/well 
in 96-well plates and incubated with 100 μg/mL ovalbumin (OVA, 
chicken egg albumin grade V; Sigma Chemical Co., St Louis, 
MO, USA) or 10 μL/mL phytohemagglutinin (PHA)-M (GIBCO 
BRL) for 48 hr, with 1 μCi of [3H]-thymidine added to each well 
for the final 12 hr. The cells were harvested onto microfiber fil-
ters (Simport, Beloeil, Canada) and the radioactivity on the dried 
filters was measured in a liquid scintillation counter. All samples 
were assayed in triplicate.
Cytokine assays
The supernatants of PHA-stimulated cells were obtained after 
48 hr in culture and stored at -70°C until assayed for the cyto-
kines, IL-13 and IFN-γ, by enzyme-linked immunosorbent as-
says (ELISA) using commercially available kits (R & D Systems, 
Minneapolis, MN, USA) according to the manufacturer’s instruc-
tions. All supernatants were assayed in duplicate. The limits of 
detection were 62.5 pg/mL for IL-13 and 15.6 pg/mL for IFN-γ.
Statistical analysis
Associations between log-transformed cord blood immune re-
sponses and the prevalence of AD at 12 months were estimated 
using chi-square tests and multiple logistic regression analyses, 
expressed as adjusted odds ratios (aOR) with 95% confidence 
intervals (CIs). Multivariate models were adjusted for child’s sex, 
season of birth, maternal age at delivery, gestational period, ma-
ternal education level and parental allergy history. All statistical 
analyses were performed using SPSS 18.0 software, with a P val-
ue < 0.05 considered statistically significant.
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Ethics statement
The study protocol was approved by the institutional review 
board of Asan Medical Center (IRB No. 2008-0616), Samsung 
Medical Center (IRB No. 2009-02-021), Yonsei University (IRB 
No. 4-2008-0588) and CHA Medical Center (IRB No. 2010-010). 
Informed consent was confirmed by each IRB and obtained 
from the parents of each infant.
RESULTS
Characteristics of the study population
The study included 412 infants (229 boys and 183 girls) and their 
families (Table 1). The mean maternal age at delivery was 32.3 
yr, with the time of delivery ranging from 37 to 42 weeks of ges-
tation, and 68.0% of the infants being delivered vaginally. We 
found that 25.2% of these infants were born during the spring, 
19.5% during the summer, 30.1% during the fall and 25.2% dur-
ing the winter. Of the mothers, 23.7% had at least graduated col-
lege and 60.9% were exposed to secondhand smoke during 
pregnancy. We found that 15.0% of the infants had at least one 
parent with a history of AD, and 28.2% were diagnosed with AD 
at 12 months of age (Table 2).
Factors associated with development of atopic dermatitis 
at 12 months
When we assessed factors associated with the development of 
AD at 12 months, we found that the prevalence of AD was higher 
in boys than in girls (OR 1.97, 95% CI 1.26-3.09, P = 0.003) and in 
infants delivered by cesarean section than those delivered vagi-
nally (OR 2.03, 95% CI 1.28-3.26, P = 0.003). There was no asso-
ciation, however, between AD and season of birth (P = 0.810) 
or maternal exposure to secondhand smoke during pregnancy 
(P = 0.782). Infants with a parental history of AD were at signifi-
cantly higher risk of developing AD at 12 months than those 
without parental history (OR 2.34, 95% CI 1.29-4.24, P = 0.005). 
Table 1. Characteristics of the study population
Characteristics
Delivery age (yr), mean (range) 32.3 (23.0-42.0)
Sex of infants (male:female) 229:183
Gestational age at birth (weeks), mean (range) 39.2 (37.0-41.4)
Mode of delivery (vaginal delivery: cesarean section) 261:123
Season at birth
   Spring, n (%)
   Summer, n (%)
   Fall, n (%)
   Winter, n (%)
 
104 (25.2)
  80 (19.4)
124 (30.1)
104 (25.2)
Maternal education level 
   Low, n (%)
   High, n (%)
 
300 (76.3)
  93 (23.7)
Secondhand smoke (SHS) exposure during pregnancy 234 (60.9)
Parental history of atopic dermatitis, n (%)   54 (15.0)
Diagnosis of atopic dermatitis at 12 months, n (%) 116 (28.2)
Table 2. Risk factors associated with the development of atopic dermatitis at 12 months
Risk factors
AD (+) 
n = 116
AD (-) 
n = 296 OR (95% CI)  P  value
n % n %
Gender
   Female 
   Male
38
78
 
32.8
67.2
145
151
 
49.0
51.0 1.97 (1.26-3.09) 0.003
Mode of delivery
   Vaginal delivery
   Cesarean section
61
47
 
56.6
43.5
200
  76
 
72.5
27.5 2.03 (1.28-3.22) 0.003
Season of birth
   Spring
   Summer
   Fall
   Winter
27
23
39
27
 
23.3
19.8
33.6
23.3
  77
  57
  85
  77
 
26.0
19.3
28.7
26.0
0.810
SHS exposure during 
   pregnancy
   No
   Yes
41
67
 
 
38.0
62.0
109
167
 
 
39.5
60.5 1.07 (0.68-1.69) 0.782
Parental history of AD
   No
   Yes
78
24
 
76.5
23.5
228
  30
 
88.4
11.6 2.34 (1.29-4.24) 0.005
Maternal education level
   Low
   High
77
32
 
70.6
29.4
223
  61
 
78.5
21.5 1.52 (0.92-2.51) 0.101
AD, atopic dermatitis; SHS, secondhand smoke.
Table 3. Association between parental history of allergic diseases and diagnosis of atopic dermatitis at 12 months
Parental history Diagnosis of AD OR (95% CI) P  value aOR* (95% CI) P  value
Maternal asthma Yes (2/9)
No (107/384)
0.74 (0.15-3.62)
1.00
0.710   3.08 (0.36-26.15)
1.00
0.302
Maternal AR Yes (28/85)
No (81/308)
1.38 (0.82-2.31)
1.00
0.227 1.55 (0.81-2.99)
1.00
0.189
Maternal AD Yes (14/31)
No (95/360)
2.30 (1.09-4.84)
1.00
0.029 3.22 (1.14-9.08)
1.00
0.027
Paternal asthma Yes (7/17)
No (98/350)
1.80 (0.67-4.86)
1.00
0.246 1.18 (0.25-5.47)
1.00
0.837
Paternal AR Yes (26/81) 
No (79/286)
1.24 (0.73-2.11)
1.00
0.432 0.98 (0.50-1.94)
1.00
0.959
Paternal AD Yes (12/25)
No (93/342)
2.47 (1.09-5.61)
1.00
0.031   5.65 (1.97-16.21)
1.00
0.001
*Adjusted for gender, maternal age at parity, gestational age, mode of delivery, parental history of atopic dermatitis, maternal education level, and season of birth. AR, allergic 
rhinitis; AD, atopic dermatitis.
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However, maternal education level was not associated with the 
development of AD at 12 months (P = 0.101).
 The associations between AD in infants and parental history 
of allergic disease, including asthma, allergic rhinitis, and AD 
are shown in Table 3. Maternal history of asthma (P = 0.302) 
and allergic rhinitis (P = 0.189) was not associated with AD in 
infants. However, maternal history of AD was associated with 
AD in infants by both univariate analysis (OR 2.30, 95% CI 1.09-
4.84, P = 0.029) and after adjustment (OR 3.22, 95% CI 1.14-9.08, 
P = 0.027). Similarly, paternal history of asthma (P = 0.837) and 
allergic rhinitis (P = 0.959) was not associated with AD in infants, 
whereas paternal history of AD was associated with the develop-
ment of AD in infants when adjusted for gender, maternal age 
at parity, gestational age, mode of delivery, maternal education 
level, and season of birth (OR 5.65, 95% CI 1.97-16.21, P = 0.001).
Proliferation assays of cord blood
WBC (P = 0.900) and eosinophil counts (P = 0.920), and total 
IgE levels (P = 0.615) in cord blood did not differ significantly 
between infants with and without AD (Table 4). Similarly, the 
cellular proliferative response of cord blood to OVA stimulation 
did not differ significantly between infants with and without AD 
(7.3 ± 1.0 cpm vs 7.8 ± 1.0 cpm, P = 0.098) (Table 4), nor did the 
ratio of cellular proliferative response of OVA-stimulated to -un-
stimulated cells between the groups with and without AD (0.6 ±  
0.4 cpm vs 0.6 ± 0.5 cpm, P = 0.771) (Fig. 1). 
 When cord blood was stimulated with PHA, cellular prolifer-
ative response did not differ between infants with and without 
AD (11.3 ± 0.5 cpm vs 11.3 ± 0.9 cpm, P = 0.525) (Table 4). How-
ever, the ratio of cellular proliferative response of PHA-stimulated 
to -unstimulated cells was significantly higher in infants with than 
without AD (4.5 ± 0.9 cpm vs 4.1 ± 1.1 cpm, P = 0.048) (Fig. 1).
Cytokine levels of cord blood
When we compared the levels of cytokines in the supernatants 
of PHA-stimulated cells of infants with and without AD (Table 
4), we found no differences in the levels of IL-13 (P = 0.468) and 
IFN-γ (P = 0.231). In addition, the IFN-γ/IL-13 ratio did not dif-
fer between groups after adjustment for gender, maternal age at 
parity, gestational age, mode of delivery, maternal education 
level, season of birth and parental history of AD (P = 0.955). 
 
DISCUSSION
We report the results of a prospective birth cohort study in Korea 
of risk factors for allergic diseases, especially AD, in children, 
and the immunologic markers for AD in their cord blood. We 
found that gender, mode of delivery and parental history of AD 
were important independent risk factors for diagnosis of AD at 
12 months. We also found that CBMC proliferation in response 
Table 4. Cellular composition and cytokine levels of cord blood of infants with and 
without atopic dermatitis at 12 months 
Cells and responses
AD (+) AD (-)
  P  value*
n Mean ± SE n Mean ± SE
Cells in cord blood
   WBC (× 103/µL)
   Eosinophils (%)
   Total IgE (IU/mL)
30
27
68
 
2.4 ± 0.4
1.1 ± 0.9
-1.2 ± 1.1
  83
  78
144
 
2.4 ± 0.4
0.9 ± 1.0
-1.3 ± 1.1
 
0.900
0.920
0.615
CBMC proliferative response
   OVA stimulation (cpm)
   PHA stimulation (cpm)
   OVA/media
   PHA/media
50
51
50
51
 
7.3 ± 1.0
11.3 ± 0.5
0.6 ± 0.4
4.5 ± 0.9
106
106
106
106
 
7.8 ± 1.0
11.3 ± 0.9
0.6 ± 0.5
4.1 ± 1.1
 
0.098
0.525
0.771
0.048
Cytokine levels after PHA 
   stimulation
   IL-13 (pg/mL)
   IFN-γ (pg/mL)
   IFN-γ/IL-13
53
52
51
 
 
7.0 ± 1.3
5.3 ± 1.5
-1.7 ± 1.6
106
100
100
 
 
7.2 ± 1.2
5.4 ± 1.3
-2.0 ± 1.4
 
 
0.468
0.231
0.955
Data are all log-transformed. *Adjusted for gender, maternal age at parity, gestational 
age, mode of delivery, parental history of atopic dermatitis, maternal education level, 
and season of birth. AD, atopic dermatitis; WBC, white blood cell; CBMC, cord blood 
mononuclear cell; OVA, ovalbumin; PHA, phytohaemagglutinin.
Fig. 1. Cellular proliferative responses to ovalbumin (OVA) and phytohemagglutinin (PHA) stimulation in infants with and without atopic dermatitis at 12 months. Ratio of cellular 
proliferative responses in the presence and absence of (A) OVA and (B) PHA. The median values are presented and differences between the groups were reported as P  values.
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to PHA stimulation may be a predictor of AD during infancy. 
However, there were no significant differences in IFN-γ and IL-
13 levels following PHA stimulation of cord blood cells in infants 
with and without AD. 
 Several studies have reported that a maternal, but not a pa-
ternal, history of asthma or allergic disease is associated with 
the development of allergic diseases in infants (11, 16). In con-
trast, we found that both maternal and paternal histories of AD 
were associated with the development of AD in their offspring, 
suggesting that genetic influences may affect the early develop-
ment of AD. 
 Several studies have reported that season of birth affected 
cord blood IgE level, although peak IgE levels differed among 
these studies (11, 16). We found, however, that season of birth 
did not differ between infants with and without AD at 12 months 
of age.
 We also found that delivery by cesarean section was an inde-
pendent risk factor compared with vaginal delivery for the de-
velopment of AD at 12 months of age. Although several studies 
have reported an association between allergic diseases and de-
livery by cesarean section (17), others have not (18, 19). Accord-
ing to the hygiene hypothesis, unhygienic exposure decreases 
the risk of allergic disorders. Vaginally delivered children acquire 
their intestinal flora through the mother’s vaginal tract; these 
flora reflect the mother’s intestinal flora, mainly lactobacilli and 
bifidobacteria. In contrast, children born by cesarean section 
acquire their intestinal bacteria from skin contact and environ-
mental surfaces. A recent meta-analysis reported that delivery 
by cesarean section increases the subsequent risk of asthma in 
children by about 20% (20).
 Many studies have suggested that cord blood factors are as-
sociated with the development of allergic diseases. For exam-
ple, children with high cord blood IgE levels have been reported 
to have a five-fold greater risk for developing asthma by 11 yr of 
age (21), although other studies failed to find such association 
(22). In contrast, family history of atopy was reported to be a bet-
ter predictor of atopy than cord blood IgE (22). These discrep-
ancies may be due to several factors, such as the cut-off level of 
cord blood IgE level, the duration of follow-up, ethnicity, out-
come diseases, and populations (i.e. high-risk group vs the gen-
eral population). We found that eosinophil counts, WBC counts, 
and total IgE levels in cord blood were similar in infants with 
and without AD. Since our group of infants was from the gener-
al population, our findings may reflect the actual condition of 
Korean infants. Our findings, however, require confirmation by 
larger study groups with longer follow-up duration. 
 The ability of proliferative response of cord blood cells to pre-
dict the development of allergic diseases is unclear, with some 
reports showing that proliferative response was not useful in 
predicting the outcome of allergic diseases (23, 24). In addition, 
immunoproliferative responses at 1 yr were reported to be un-
related to maternal mite allergen exposure during pregnancy, 
but were associated with increasing Der p 1 exposure at 1 yr (25). 
These findings suggest that infants early in life, but not in utero, 
become sensitized to inhaled allergens. In contrast, recent re-
ports have shown that CBMCs obtained during gestation can 
proliferate after stimulation with various nutritive and inhaled 
allergens (26), as well as other types of allergens (27, 28). We 
found that CBMCs from infants with AD proliferated in response 
to PHA, but not OVA, stimulation, suggesting that potent cellu-
lar proliferation to nonspecific stimulation at birth may be as-
sociated with the development of allergic diseases, despite an 
absence of specific sensitization.
 Neonatal T cells have been reported to preferentially show a 
Th2-dominant cytokine pattern and reduced Th1 cytokine pro-
duction (29), even if they are pluripotent cells with the ability to 
produce both Th1 and Th2 cytokines (30). Changes in cytokine 
production may be associated with the subsequent development 
of allergic diseases. CD4+IL-13+ lymphocytes from CBMCs de-
rived from atopic mothers were found to be associated with 
wheezing during the first year of life (10). Moreover, enhanced 
IL-13 levels at birth were associated with the subsequent devel-
opment of atopic symptoms at 3 yr of age (23). In addition, in 
previous studies, IFN-γ release was significantly reduced in chil-
dren with subsequent development of atopic disorders (15), 
whereas others, including our group, reported no association 
between IFN-γ response and allergy or sensitization (31). This 
may be due to differences among the recruited groups. Most of 
these studies included high-risk neonates with atopic parents, 
whereas our study group was recruited from the general popu-
lation. Differences may also be due to methodological differ-
ences in cell culture technique, differences in stimulated aller-
gens, and definitions of outcome.
 IL-13 production has been related to allergic diseases, with 
IL-13 and IFN-γ production being markers of neonatal CD4+ T 
cell differentiation (32). In addition, IL-13 production has been 
correlated with the development of asthma and AD by the age 
of 1 yr (32), and with atopic symptoms at age 3 yr (22), suggest-
ing that IL-13 may be an early marker for atopic disease in neo-
nates who develop AD. We found, however, that levels of IL-13 
production in response to PHA stimulation were similar in in-
fants with and without AD. Since the development of allergic 
diseases is associated with a balance between Th1 and Th2 re-
sponses, increased IL-13 production may not independently 
affect the development of AD. Moreover, the IFN-γ/IL-13 was 
similar in infants with and without AD, suggesting that cytokine 
production in cord blood may not predict the development of 
AD during infancy. 
 The main outcome of this study was diagnosis of AD by pedi-
atric allergy specialists. Although most other studies have used 
questionnaires completed by parents to define allergic diseas-
es, we used a diagnosis by pediatric allergy specialists. Although 
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the latter may be more accurate, the small number of patients 
can be limitation of our study. Allergic diseases show various 
phenotypes, so accurate definitions and diagnoses are very im-
portant. 
 The fetal period and early childhood are critical periods for 
detecting the onset of allergic diseases. Thus, interventions dur-
ing this time may be effective in preventing allergic diseases. 
In conclusion, we found that gender, mode of delivery and pa-
rental history of AD had an effect on the development of AD at 
12 months. A high cellular proliferative response of cord blood 
to PHA, rather than cytokine production in response to PHA, 
may be associated with infant development of AD at 12 months. 
Therefore, evaluating environmental factors and cellular status 
of cord blood may predict the development of AD in early in-
fancy and these can be applied to prevent the development of 
allergic diseases. 
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